Javelin Oncology, Inc. — Form D
Javelin Oncology, Inc. of LEBANON, NH, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-10. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-12-10
- Form: D
- Accession: 0001796219-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.5M
- Remaining: $1.5M
- Investors: 10
- Date of first sale: 2019-12-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-355190
Issuer
- Name: Javelin Oncology, Inc.
- CIK: 0001796219
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 16 CAVENDISH CT., LEBANON, NH, 03766
- Phone: 603-643-7182
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Eric Achtman | Director | Lebanon, NH |
| Jake Reder | Director | Lebanon, NH |
| Daniel Rhodes | Director | Ann Arbor, MI |
| Anthony Cooper | Executive Officer | Lebanon, NH |
| Matthew Martin | Executive Officer | Ann Arbor, MI |
| Daniel Rhodes | Executive Officer | Ann Arbor, MI |
More